Unilever PLC: First Half 2024 Results Summary
Business Context and Reporting Period
This Form 6-K filing reports Unilever PLC's unaudited financial results for the six months ended June 30, 2024. The company, a global leader in Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream, continues to execute its "Growth Action Plan," focusing on high-quality sales growth, gross margin expansion, and the strategic separation of its Ice Cream business.
Key Financial Metrics
| Metric | First Half 2024 | First Half 2023 | Change |
|---|---|---|---|
| Turnover | €31.1 billion | €30.4 billion | +2.3% |
| Underlying Sales Growth (USG) | 4.1% | 2.3% | +180bps |
| Underlying Operating Profit | €6.1 billion | €5.2 billion | +17.1% |
| Underlying Operating Margin | 19.6% | 17.1% | +250bps |
| Net Profit | €4.0 billion | €3.9 billion | +3.5% |
| Underlying EPS | €1.62 | €1.39 | +16.3% |
| Diluted EPS (GAAP) | €1.47 | €1.40 | +5.4% |
| Free Cash Flow | €2.2 billion | €2.5 billion | -€0.3 billion |
| Net Debt | €25.2 billion | €24.3 billion | +€0.9 billion |
Material Changes vs. Prior Period
- Volume-Led Growth: Underlying sales growth of 4.1% was driven by volume growth of 2.6%, marking the third consecutive quarter of positive volume growth. Power Brands (approx. 75% of turnover) delivered 5.7% USG.
- Margin Expansion: Underlying operating margin increased by 250 basis points to 19.6%, supported by a 420bps improvement in gross margin. This allowed for increased brand and marketing investment (up 180bps to 15.1% of turnover).
- Segment Performance:
- Beauty & Wellbeing: Strongest performer with 7.1% USG, driven by Health & Wellbeing and Prestige Beauty.
- Personal Care: 5.6% USG, led by Deodorants.
- Home Care: 3.3% USG with 4.6% volume growth, offset by negative price growth due to commodity deflation.
- Nutrition: 3.2% USG, driven by price with flat volumes in H1 (volumes turned positive in Q2).
- Ice Cream: Weakest performer with 0.6% USG and negative volume (-1.0%) due to a soft start to the season in Europe and weakness in China.
- Geography: Emerging markets grew 5.1% (volume +3.8%), while Developed markets grew 2.8% (volume +0.8%).
Outlook, Guidance, and Risks
- 2024 Guidance:
- Underlying Sales Growth: Expected to remain within the multi-year range of 3% to 5%, with the majority driven by volume.
- Underlying Operating Margin: Expected to be at least 18% for the full year. Management expects margin progression in the second half to be smaller than in the first half due to one-off factors in H1 (low prior year comparator, carry-over pricing).
- Tax Rate: Underlying effective tax rate guidance raised to around 26% for the full year.
- Capital Allocation:
- Dividends: Quarterly dividend increased by 3.0% to €0.4396 per share.
- Buybacks: A €1.5 billion share buyback programme commenced in May; €375 million executed in H1.
- M&A: Completed acquisition of K18 (hair care) and disposal of Elida Beauty. Agreements announced to sell Pureit and stake in Qinyuan Group.
- Strategic Initiatives: Separation of the Ice Cream business is on track to complete by end of 2025. A comprehensive productivity programme is underway.
- Risks:
- Russia: Operations represent ~1% of turnover and profit. Risk of asset write-downs or inability to continue operations remains.
- Geopolitics: Sales decline in Indonesia due to consumer avoidance of multinational brands linked to Middle East tensions.
- Commodities: Cost inflation in cocoa and sugar impacting Ice Cream margins.
Investor Verification Checklist
- Volume Sustainability: Verify if the sequential improvement in volume growth (2.6% in H1, 2.9% in Q2) can be sustained in the second half, particularly in Developed markets.
- Margin Quality: Assess the durability of the 420bps gross margin improvement, noting management's warning that H1 benefits included non-recurring factors (low prior year costs, inflation carry-over).
- Ice Cream Separation: Monitor progress on the legal and operational carve-out of the Ice Cream business, which is currently underperforming.
- China & Indonesia Exposure: Review specific market dynamics in China (weakness across categories) and Indonesia (geopolitical impact) given their weight in Emerging Markets.
- Free Cash Flow: Analyze the seasonal working capital outflow that reduced FCF to €2.2bn despite strong operating profit.